Archive | Journals,Papers & Reports

Molecule identified that helps give resident T cells in the skin their anti-cancer punch

The molecule CD103 is key to the long-term residence of T cells in the skin and to their anti-tumor function, report a team of researchers at the Medical University of South Carolina (MUSC) and the Dartmouth-Hitchcock Norris Cotton Cancer Center In the April 14, 2017 Science Immunology.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

Could levels of ANGPT2 predict clinical outcomes for patients with advanced melanoma?

Investigators from the Dana-Farber Cancer Institute (Boston, MA, USA) have identified the serum-based protein angiopoietin-2 (ANGPT2) as a prognostic biomarker that could be utilized to predict clinical outcomes with patients with advanced melanoma and could identify those patients that might respond to immune checkpoint therapy.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

Australian Clinical Study Published in British Journal of Dermatology Presents Further Benefits With Nevisense

The Australian study previously presented at the World Congress of Cancers of the Skin showing that Nevisense can detect malignant melanoma three months earlier in follow-up cases and reduce the need for follow-up by nearly half, has now been published in the British Journal of Dermatology (BJD).

Read the full story

Posted in Melanoma In The News, Clinical Trials, Journals,Papers & Reports

Cause of rare acral and mucosal melanomas not linked to sun exposure, study finds

Australian scientists have discovered that the danger of melanoma is not just related to sun exposure.

Read the full story

Posted in Melanoma In The News, Journals,Papers & Reports

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories